Effect of Aronia Berry Consumption on Inflammatory Parameters
Consumption of Anti-Inflammatory Effects of Aronia (Aronia Melanocarpa) Berry in Patients With Chronic Obstructive Pulmonary Disease
Amasya University
50 participants
Nov 15, 2024
INTERVENTIONAL
Conditions
Summary
The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assessed both before and after the intervention. Dietary intake records will also be collected and analyzed.
Eligibility
Inclusion Criteria7
- Aged 50-80 years
- Diagnosed with COPD
- Not following a vegetarian or vegan diet
- Willing to consume the provided aronia berry (black chokeberry)
- Non-smokers
- Have signed the informed consent form
- Has not undergone endobronchial tube or valve surgery in the last two years.
Exclusion Criteria11
- Presence of associated chronic inflammatory/rheumatic diseases
- Chronic infections that may create a prothrombotic state
- Chronic kidney disease (CKD)
- Malignancy
- Hereditary thrombophilia
- Essential thrombocythemia
- Diagnosed endocrine disorders
- Malabsorption disorders
- Allergy to any food or berry fruits
- Smoking
- Participants who did not sign the informed consent form
Interventions
The placebo group, who will consume placebo powder (n=25).
The aronia group, who will consume 30 g of freeze-dried aronia powder (n=25)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06702696